Definitive Contract HHSN272201700072C
Award Date
7/24/17
Potential Completion Date
7/31/18
Potential Value
$225K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Qoolabs Inc.
Ultimate Awardee
Not listed
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
12
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This is a $1,500,000.00 SBIR Phase II contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Qoolabs Inc., a small disadvantaged and woman-owned business located in Carlsbad, California. The contract is for research and development of medical technologies related to infectious diseases, immunology, and COVID-19 detection, including the development of affinity reagents,...
This is a $300,000 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Qoolabs Inc., a small disadvantaged business located in Carlsbad, California. The contract is for research and development under the Small Business Innovation Research (SBIR) program, with a period of performance through September 2025. Qoolabs is developing medical technologies related to infectious diseases, immunology,...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Small Business Innovation Research (SBIR) Program Phase I contract to Nanocomposix, Inc., a manufacturer of engineered nanoparticles, to build a proof of concept lateral flow rapid diagnostic to identify the serological status of individuals with respect to cytomegalovirus (CMV). The contract, valued at $224,887.00, requires the contractor to characterize...
This $300,000 firm fixed price contract was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Qoolabs Inc. of San Diego, California. The contract is for the development of point-of-care hepatitis C virus core antigen detection and was awarded under the Small Business Innovation Research program's solicitation PHS-2021-1. This total small business set-aside opportunity sought proposals for innovative...
This federal contract award is for SBIR Phase II research and development work by Qoolabs Inc., a self-certified small disadvantaged business. The $749,999 cost-plus-fixed-fee contract was awarded on September 5, 2017 by the Department of Health and Human Services Centers for Disease Control and Prevention. The work is being performed in Atlanta, Georgia and involves the development of medical technologies related to infectious diseases, immunology, and cancer detection. This includes research...
Qoolabs Inc. has been awarded a $400,000 firm fixed price contract by the Department of Health and Human Services National Institutes of Health National Cancer Institute to develop an at-home rapid test for hepatitis C virus detection. This contract was awarded under the Small Business Innovation Research Program Phase I action, which is set aside for small businesses. Work will be conducted by Qoolabs in San Diego, California through September 2023. The contract responds to a 2020...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Small Business Innovation Research (SBIR) Phase I contract to Qoolabs Inc., a self-certified small disadvantaged business, to conduct research on finding human carriers of taeniasis to prevent neurocysticercosis epilepsy. The $150,000 firm-fixed-price contract was awarded on September 17, 2018 with a completion date of September 16, 2019. Qoolabs Inc. has received over $4 million in prime federal...
This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Luna Innovations Incorporated, a small business, to develop Cytomegalovirus (CMV) Immunoglobulin G (IgG) and Immunoglobulin M (IgM) lateral flow assays required to support a large-scale CMV vaccination trial. The $1,499,994.00 award has a firm fixed price and is a Small Business Technology Transfer (STTR) Phase II contract with a...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Small Business Innovation Research (SBIR) Program Phase I action contract to Visby Medical, Inc., a for-profit medical diagnostics manufacturer. The $140,000.00 firm-fixed-price contract, which was set aside for small businesses, is for the development of a rapid, accurate point-of-care diagnostic test under SBIR Topic 075. Visby Medical has received...
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Qoolabs Inc., a self-certified small disadvantaged and woman-owned business. The $150,000 contract is for critical functions, with a period of performance ending on March 20, 2017. Qoolabs Inc. is a biotech company that has received over $4 million in prime federal contracts from the Department of Health and Human Services (HHS), including the National Institutes of Health (NIH),...